跳至主要内容
临床试验/EUCTR2016-000097-38-BE
EUCTR2016-000097-38-BE进行中(未招募)1 期

Randomized, double-blind, placebo-controlled study to measure 2L®ALERG (homeopathic drug) efficacy on symptoms of allergic rhinitis and allergic rhinoconjunctivitis in patients with a seasonal allergy to grass pollen - 2LALERG

abo'Life0 个研究点开始时间: 2016年1月22日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Age =18 years, male and female
  • - Symptomatic since at least two seasons and confirmed by positive skin test and/or the presence of IgE for grasses (prick test defined as positive if higher than or equal to half the negative control; IgE positive if at least class 3 (= 3.5 kU / L); these tests must have been performed at the latest at the first screening visit
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 80
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 20

排除标准

  • -Patient with an acute exacerbation of allergic rhinitis
  • -Patient with uncontrolled asthma
  • -Immunotherapy received within the last two years
  • -Patient with a known lactose intolerance
  • -Patient taking nasal or bronchial inhaled corticosteroids on a long term basis (intermittent consumption during the season is permitted provided it is mentioned in the patient’s records)

研究者

发起方
abo'Life

相似试验

Study to assess the efficacy of homeopathic 2LALERG... | 临床试验